Business · 21/01/2020
FDA Requests Public Comment on Proposed Study of Prescription Drug Names
The Food and Drug Administration is seeking public input on a proposed study to examine the promotional implications of proprietary prescription drug names, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →